Incorporation of TGF-beta 3 within collagen-hyaluronic acid scaffolds improves their chondrogenic potential.
journal contributionposted on 2021-09-02, 16:14 authored by Amos Matsiko, Tanya J. Levingstone, John Gleeson, Fergal O'BrienFergal O'Brien
Incorporation of therapeutics in the form of growth factors within biomaterials can enhance their biofunctionality. Two methods of incorporating transforming growth factor-beta 3 within collagen-hyaluronic acid scaffolds are described, markedly improving mesenchymal stem cell-mediated chondrogenic differentiation and matrix production. Such scaffolds offer control over the release of therapeutics, demonstrating their potential for repair of complex chondral defects requiring additional stimuli.
Enterprise Ireland, Commercialization Fund Technology
CommentsThe original article is available at onlinelibrary.wiley.com
Published CitationMatsiko A, Levingstone TJ, Gleeson JP, O'Brien FJ. Incorporation of TGF-beta 3 within collagen-hyaluronic acid scaffolds improves their chondrogenic potential. Advanced Healthcare Materials. 2015;4(8):1175-9.
- Anatomy and Regenerative Medicine
- Tissue Engineering Research Group (TERG)
- Amber (Advanced Material & Bioengineering Research) Centre